Invitation to Cosmo’s full-year 2022 financial results and 2023 outlook webcast presentation on 23 March 2023
- 58
|
Cosmo Pharmaceuticals N.V.
/ Key word(s): Annual Results
Dublin, Ireland – 16 March 2023: Cosmo Pharmaceuticals N.V. (SIX: COPN, XETRA: C43) (“Cosmo”) announced today that it will publish its full-year 2022 results on Thursday, 23 March 2023 at 07:00 am CET.
Cosmo invites investors, financial analysts and business/life science journalists to a live video webcast which will follow at 2:00 pm CET with Mauro Ajani, Founder and Chairman, Alessandro Della Chà, CEO, and Niall Donnelly, CFO, to discuss the 2022 financial and operating results as well as the next milestones of the company.
Live conference call and video webcast presentation: Date: Thursday, 23 March 2023 Webcast link: Chrome (recommended) or Firefox https://media.choruscall.eu/mediaframe/webcast.html?webcastid=L3HNXtf4
Via phone: Participants wishing to ask verbal questions via phone, may call the following numbers below. To ensure prompt access, please call approximately ten minutes prior to the scheduled start of the call.
The presentation and media release as well as the Annual Report 2022 will be available for download as of 07:00 am CET on 23 March 2023 at www.cosmopharma.com
The webcast, along with the presentation, will be available online shortly after the event and accessible for three months.
Contact: Hazel Winchester Head of Investor Relations Cosmo Pharmaceuticals N.V. Tel: +353 1 817 03 70
End of Media Release |
| Language: | English |
| Company: | Cosmo Pharmaceuticals N.V. |
| Riverside 2, Sir John Rogerson’s | |
| Dublin 2 Dublin | |
| Ireland | |
| Phone: | + 353 1 817 0370 |
| E-mail: | [email protected] |
| Internet: | https://www.cosmopharma.com/ |
| ISIN: | NL0011832936 |
| Listed: | SIX Swiss Exchange |
| EQS News ID: | 1583775 |
| End of News | EQS News Service |
|
|
1583775 16.03.2023 GMT/BST
EQS Group is a leading international technology provider for Digital Investor Relations, Corporate Communications and Compliance. More than 8,000 companies worldwide trust EQS’s products and services to securely, efficiently, and simultaneously fulfil complex national and international disclosure and compliance requirements, and to reach stakeholders globally.
